Becton, Dickinson & Co. (BDX)
198.91
-1.51
(-0.75%)
USD |
NYSE |
Oct 23, 16:00
198.88
-0.03
(-0.02%)
Pre-Market: 20:00
Becton, Dickinson Enterprise Value : 70.12B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 70.12B |
| October 22, 2026 | 70.54B |
| October 21, 2026 | 68.88B |
| October 20, 2026 | 68.73B |
| October 19, 2026 | 67.90B |
| October 16, 2026 | 68.17B |
| October 15, 2026 | 68.72B |
| October 14, 2026 | 67.40B |
| October 13, 2026 | 66.98B |
| October 12, 2026 | 67.40B |
| October 09, 2026 | 66.00B |
| October 08, 2026 | 65.72B |
| October 07, 2026 | 65.02B |
| October 06, 2026 | 65.06B |
| October 05, 2026 | 65.16B |
| October 02, 2026 | 64.10B |
| October 01, 2026 | 64.45B |
| September 30, 2026 | 64.70B |
| September 29, 2026 | 65.51B |
| September 28, 2026 | 66.02B |
| September 25, 2026 | 66.01B |
| September 24, 2026 | 64.76B |
| September 23, 2026 | 65.66B |
| September 22, 2026 | 65.79B |
| September 21, 2026 | 65.16B |
| Date | Value |
|---|---|
| September 18, 2026 | 65.23B |
| September 17, 2026 | 65.35B |
| September 16, 2026 | 65.48B |
| September 15, 2026 | 66.59B |
| September 14, 2026 | 65.77B |
| September 11, 2026 | 64.39B |
| September 10, 2026 | 64.00B |
| September 09, 2026 | 64.92B |
| September 08, 2026 | 64.73B |
| September 04, 2026 | 66.26B |
| September 03, 2026 | 67.05B |
| September 02, 2026 | 67.02B |
| September 01, 2026 | 66.91B |
| August 31, 2026 | 67.18B |
| August 28, 2026 | 67.57B |
| August 27, 2026 | 67.19B |
| August 26, 2026 | 67.75B |
| August 25, 2026 | 67.64B |
| August 24, 2026 | 67.90B |
| August 21, 2026 | 68.24B |
| August 20, 2026 | 67.05B |
| August 19, 2026 | 67.04B |
| August 18, 2026 | 65.18B |
| August 17, 2026 | 65.54B |
| August 14, 2026 | 65.90B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.10B |
| Boston Scientific Corp. | 78.32B |
| Stryker Corp. | 129.78B |
| Globus Medical, Inc. | 10.45B |
| Baxter International, Inc. | 19.76B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 451.00M |
| Revenue (Quarterly) | 4.983B |
| Total Expenses (Quarterly) | 4.532B |
| EPS Diluted (Quarterly) | 1.370 |
| Gross Profit Margin (Quarterly) | 46.46% |
| Profit Margin (Quarterly) | 9.05% |
| Earnings Yield | 1.67% |
| Operating Earnings Yield | 5.40% |
| Normalized Earnings Yield | -1.243 |